Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/IMRX

    Immuneering Corporation(IMRX)

    Biotechnology
    Oncology Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    BMY
    59
    RLAY
    58
    RXRX
    52
    IMRX
    50
    IMA
    50
    TGTX
    50
    MRK
    50
    AMGN
    47
    RVMD
    21
    SDGR
    18
    PGEN
    17
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-01-21
    Brakewood Harold Eugene
    Chief Business Officer
    Purchase
    +5,250
    +90.52%11,050
    $4.76$24,990View SEC filing
    2026-01-20
    Schall Thomas J.
    Director
    Purchase
    +21,645
    +40.93%74,530
    $4.67$101,041View SEC filing
    2026-01-16
    Hall Brett Matthew
    CHIEF SCIENTIFIC OFFICER
    Purchase
    +2,298
    +0.61%376,496
    $4.57$10,502View SEC filing
    2026-01-15
    Neufeld Leah R
    CHIEF PEOPLE OFFICER
    Purchase
    +2,626
    +11.25%25,970
    $4.15$10,906View SEC filing
    2026-01-14
    Feinberg Peter
    Director
    Purchase
    +20,000
    +17.32%135,441
    $4.35$86,904View SEC filing
    2025-10-07
    Feinberg Peter
    Director
    Purchase
    +7,500
    +5.02%156,766
    $6.67$50,025View SEC filing
    2025-10-02
    Morales Mallory
    Chief Accounting Officer
    Purchase
    +300
    +1.10%27,533
    $6.39$1,917View SEC filing
    2025-10-02
    Neufeld Leah R
    CHIEF PEOPLE OFFICER
    Purchase
    +800
    +3.55%23,344
    $6.38$5,103View SEC filing
    2025-10-02
    Bookman Michael
    CHIEF LEGAL OFFICER, SECRETARY
    Purchase
    +1,020
    +26.49%4,870
    $6.83$6,966View SEC filing
    2025-10-01
    Feinberg Peter
    Director
    Purchase
    +7,500
    +5.29%149,266
    $7.03$52,730View SEC filing
    2025-09-30
    Feinberg Peter
    Director
    Purchase
    +5,000
    +3.66%141,766
    $7.18$35,900View SEC filing
    2025-07-07
    HAUSMAN DIANA
    Director
    Purchase
    +5,500
    +100.00%5,500
    $3.61$19,863View SEC filing
    2025-07-07
    Neufeld Leah R
    CHIEF PEOPLE OFFICER
    Purchase
    +700
    +6.98%10,729
    $3.57$2,499View SEC filing
    2025-07-03
    Zeskind Benjamin J.
    PRESIDENT AND CEO
    Purchase
    +10,000
    +0.43%2,312,852
    $3.49$34,879View SEC filing
    2025-06-30
    Schall Thomas J.
    Director
    Purchase
    +9,500
    +21.90%52,885
    $3.66$34,788View SEC filing
    2025-06-24
    Hall Brett Matthew
    CHIEF SCIENTIFIC OFFICER
    Purchase
    +13,422
    +3.88%359,318
    $2.58$34,616View SEC filing
    2025-06-24
    Brakewood Harold Eugene
    Chief Business Officer
    Purchase
    +1,900
    +48.72%5,800
    $2.53$4,804View SEC filing
    2025-06-23
    Feinberg Peter
    Director
    Purchase
    +25,000
    +22.37%136,766
    $2.53$63,188View SEC filing
    2025-06-20
    Zeskind Benjamin J.
    PRESIDENT AND CEO
    Purchase
    +21,000
    +0.92%2,302,852
    $2.39$50,144View SEC filing
    2025-06-18
    Schall Thomas J.
    Director
    Purchase
    +40,485
    +1396.03%43,385
    $2.21$89,278View SEC filing
    2024-04-03
    Cormorant Asset Management, LP
    10% Owner
    Sale
    -400,000
    -12.14%2,895,273
    $2.90$1,160,181View SEC filing
    2024-03-25
    Feinberg Peter
    Director
    Purchase
    +25,000
    +28.81%111,766
    $2.55$63,713View SEC filing
    2024-03-25
    Brakewood Harold Eugene
    Chief Business Officer
    Purchase
    +3,900
    +100.00%3,900
    $2.57$10,015View SEC filing
    2024-03-25
    Morales Mallory
    Chief Accounting Officer
    Purchase
    +1,500
    +22.13%8,278
    $2.67$4,009View SEC filing
    2024-03-25
    Schall Thomas J.
    Director
    Purchase
    +2,900
    +100.00%2,900
    $2.55$7,385View SEC filing

    1-25 of 53

    Page 1 of 3